Mark Alles’ ADC bet TORL poaches J&J medical exec; Samsung Bioepis makes historic CEO appointment

TORL BioTherapeutics, the antibody-drug conjugate startup led by former Celgene chief Mark Alles, has brought aboard a chief medical officer with big pharma chops. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Avidity CEO says it’s ‘full steam ahead’ in DMD as stock rallies on Phase 1/2 win

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 10, 2024

Liveyon CEO Convicted in Stem Cell Scheme That Sickened Many

The former CEO of Liveyon — the stem cell company whose contaminated products sickened at least 20 people — has pleaded guilty to felony charges,

August 29, 2024

Decades After D-Day, Family of Black WWII Combat Medic Receives His Medal of Heroism

Waverly B. Woodson Jr., who was part of the only African American combat unit involved in the D-Day invasion during World War II, spent more

September 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.